title: [Splenectomy in the treatment of hairy cell leukemia].
abstract: Splenectomy still remains the method of choice in treatment of patients with hairy cell leukemia (HCL) due to high efficiency and low percentage of complications. Five-year survival of patients with HCL after splenectomy was 74%. Because of the low percent of hairy cells in the patient's blood the diagnosis of HCL should widely include trephine biopsy of the bone marrow as well as immunological studies of the leukemic cells. In order to detect pathological processes in the spleen and estimate the topographo-anatomical alterations in the left quadrant of the abdomen before operation, it is expedient to use computed tomography, ultrasound examination, scintigraphy.
authors: M Ia
authors: MIa
authors: Iudin
authors: L L
authors: LL
authors: Iavorkovskiĭ
authors: M A
authors: MA
authors: Liepi'nsh
mesh_terms: D000328:Adult; D000368:Aged; D001853:Bone Marrow / Q000473:pathology; D005260:Female; D006801:Humans; D007943:Leukemia, Hairy Cell / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D011300:Preoperative Care; D013154:Spleen / Q000473:pathology; D013156:Splenectomy
vernacular_title: Splenektomiia v lechenii volosatokletochnogo leĭkoza.